APBI 2016
Interaction between local & systemic treatment
Stage
Benefit HT DFS (%) 4.9-9.5 5.7-8.2 7.8-11.1 9.6-13.9 8.1-11.6 10.8-15.7 12.7-18.7
Benefit HT
OS (%)
(all 65y;N0;ER+;Her-)
T1a-bG1-3
0.3-1.4
T1cG1 T1cG2 T1cG3
0.9 2.0 3.3 2.4 4.3 5.9
G1 G2 G3
T2 <3cm T2 <3cm T2 <3cm
Made with FlippingBook